Retinitis pigmentosa 84 is a genetic eye condition that slowly damages the light-sensing cells in the retina. People with Retinitis pigmentosa 84 often notice night vision trouble and gradual loss of side vision. It usually starts in childhood or young adulthood and progresses over many years. There is no cure, but low-vision aids, vitamin A under medical guidance, and genetic counseling can help, and some may qualify for clinical trials. Most people with Retinitis pigmentosa 84 have a normal lifespan, but vision loss can affect daily life and work, so regular eye care is important.
Overview
Retinitis pigmentosa 84Symptoms
Retinitis pigmentosa 84 causes night blindness, trouble seeing in dim light, and increasing loss of side vision. Many develop tunnel vision, glare sensitivity, and difficulty adjusting between light and dark. Some notice light flashes or reduced color and detail.
Outlook and prognosis
Many living with retinitis pigmentosa 84 notice night blindness first, then gradually narrowing side vision over years. Central reading vision often lasts into mid‑ or later adulthood, though rates vary. Regular eye care, low‑vision tools, and emerging therapies can help maintain independence.
Causes and risk factors
Retinitis pigmentosa 84 is caused by damaging retinal gene changes—inheritance may be dominant, recessive, X‑linked, or new. Family history and parental relatedness raise risk. Smoking and intense light may hasten progression; early symptoms of Retinitis pigmentosa 84 guide testing.
Genetic influences
Genetics play a central role in Retinitis pigmentosa 84; most cases result from inherited gene changes. Variants can be autosomal dominant, recessive, or X‑linked, shaping age at onset, progression, and severity. Genetic testing clarifies the cause, guides counseling, and identifies trial eligibility.
Diagnosis
Doctors suspect Retinitis pigmentosa 84 from night-vision problems and characteristic eye exam findings. Confirmation uses visual field testing, electroretinography, and retinal imaging. Genetic diagnosis of Retinitis pigmentosa 84 relies on genetic testing to identify the causative variant.
Treatment and drugs
Treatment for retinitis pigmentosa 84 focuses on protecting remaining vision, easing day-to-day seeing, and supporting eye health. Care often includes vitamin A palmitate (when appropriate), UV-blocking lenses, low-vision aids, orientation training, and management of swelling with eye drops or tablets. Genetic counseling, clinical trial discussion, and monitoring for cataract or macular edema are common parts of care.
Symptoms
Trouble seeing in dim light and narrowing side vision are common early features of retinitis pigmentosa 84. In daily routines, this might show up as small but noticeable changes. You might notice more stumbles at dusk or need extra light to move around safely at night. Over time, central vision and color perception can also be affected.
Seeing in dim light, at dusk, or in dark rooms becomes hard. Many people need brighter lamps or extra time for their eyes to adjust. Retinitis pigmentosa 84 often starts this way.
Side vision narrows, sometimes called tunnel vision. This can lead to bumping into doorframes or missing steps, especially in new places. Loved ones often notice the changes first.
Bright lights and glare can feel harsh or painful. Walking out into sunlight or facing oncoming headlights may be uncomfortable. Sunglasses, hats, or tinted lenses can help.
Eyes take longer to adapt when lights dim. Entering a theater or stepping outside at night can feel disorienting. Clinicians call this delayed dark adaptation, which means the eyes need extra time to work in low light.
How people usually first notice Retinitis pigmentosa 84?
Many people first notice retinitis pigmentosa 84 when night vision starts slipping—dim rooms, dusk, or driving at night feel unusually hard—followed by trouble seeing off to the sides, as if the edges of the visual scene are fading. Over time, this “tunnel vision” makes it easier to bump into objects just outside the center view, while reading and color vision in good light may stay relatively clear for a while. For some, a family history or a routine eye exam that finds characteristic retinal changes leads to the first clue before daily symptoms become obvious—these are often described as the first signs of retinitis pigmentosa 84.
Types of Retinitis pigmentosa 84
Retinitis pigmentosa 84 is an inherited form of retinal degeneration linked to changes in the RP1 gene; it sits within the larger retinitis pigmentosa (RP) family but has its own patterns. People with RP often first notice night vision trouble and narrowing side vision, which can gradually affect reading and face recognition in low light. Symptoms don’t always look the same for everyone. Below are the main variants of RP84 described in medical genetics, so when someone asks about types of retinitis pigmentosa 84, they usually mean how it’s inherited and how quickly vision changes over time.
Autosomal dominant
This variant is passed from an affected parent about half the time to each child. It often starts with night blindness in adolescence or early adulthood, with side vision slowly narrowing.
Autosomal recessive
This variant appears when both parents carry a nonworking copy but do not have symptoms themselves. Onset can be earlier and progression may be faster, with more noticeable night and peripheral vision loss in youth.
X-linked (rare)
This variant involves the X chromosome and mainly affects males, while females may have milder features due to X-inactivation. When present, it can progress more quickly with earlier night blindness and tunnel vision.
What genetics can tell you about symptoms
Some people with retinitis pigmentosa 84 (RP84) develop night blindness first, then gradual tunnel vision, because variants in the RPGR gene disrupt proteins that help photoreceptor cells clear waste and stay healthy. As rods fail and cones later weaken, dim light seeing, side vision, and color sharpness decline.
Causes and risk factors
Retinitis pigmentosa 84 is caused by a change in a single gene that disrupts the retina’s light-sensing cells. Doctors distinguish between risk factors you can change and those you can’t. The non‑modifiable part is inheritance, which may come from one or both parents or from a new gene change in you. Modifiable factors like smoking, poor control of diabetes, and long, unprotected exposure to bright sunlight may speed vision changes, and healthy habits may help support retinal health. Family history is the main risk factor for retinitis pigmentosa 84, and people in the same family can still be affected at different ages and speeds.
Environmental and biological risk factors
Environmental and biological influences on retinitis pigmentosa 84 are limited compared with conditions that develop over time. Doctors often group risks into internal (biological) and external (environmental). For this diagnosis, most risk comes from internal factors present at conception, and only a few outside exposures have any proven link. If you're reading about early symptoms of retinitis pigmentosa 84, it can also help to know which factors may slightly raise the chance of it occurring.
A higher parent age can slightly increase the chance of new changes arising in egg or sperm at conception, which can lead to single‑gene conditions such as retinitis pigmentosa 84. The absolute increase in risk is small for any one pregnancy. Most older parents have children without this condition.
Very high levels of ionizing radiation to either parent before conception can increase the chance of new changes in reproductive cells. Everyday medical imaging uses much lower doses and is carefully controlled. Such high exposures are uncommon.
Genetic risk factors
Family history often points toward an inherited cause. Retinitis pigmentosa 84 sits within a broad group of gene-based retinal conditions, and genetic causes of Retinitis pigmentosa 84 can differ across families. Inheritance patterns vary, which affects who is at risk and how vision changes unfold over time. Carrying a genetic change doesn’t guarantee the condition will appear.
Many possible genes: Dozens of different genes can lead to similar retinal changes. Retinitis pigmentosa 84 describes one gene-defined subtype within this wide genetic mix. Pinpointing the exact gene helps with prognosis and family planning.
Dominant inheritance: A single altered copy of a gene can cause disease, giving a 50% chance to each child. Features can differ between relatives because of variable expression.
Recessive inheritance: Two nonworking copies are needed, with each parent typically a symptom-free carrier. Each pregnancy has a 25% chance of an affected child. Prior family history may be absent.
X-linked inheritance: A change on the X chromosome can cause more severe vision loss in males, while females may have milder signs. Sons of carrier females have a 50% chance to be affected. Daughters may be carriers or have milder symptoms.
New mutation: Some cases result from a gene change that appears for the first time in an individual. This can make Retinitis pigmentosa 84 show up in a family with no previous history. The change can still be passed to future children.
Modifier genes: Variants in other genes can soften or intensify symptoms. This helps explain why two people with the same main change can have different experiences. It can also shift the age when symptoms begin.
Gene deletions/duplications: Missing or extra pieces of a gene can disrupt how cells work. Standard sequencing may miss these, so deletion/duplication analysis can be important. Finding them clarifies recurrence risk for relatives.
Ancestry-linked variants: Certain communities have founder variants that are more common. Knowing family origins can steer testing toward likely genes in Retinitis pigmentosa 84. This can raise the chance of identifying the cause.
Two-gene cause: In rare situations, changes in two different genes together cause disease. This has been reported in retinitis pigmentosa and can complicate risk estimates. Specialized testing can uncover these combinations.
Silent in some: Not everyone with a disease-causing change develops symptoms, or they may appear later in life. This can make family patterns look irregular in Retinitis pigmentosa 84. Genetic counseling can help interpret these findings.
Parental relatedness: When parents are closely related, the chance they carry the same rare variant is higher. This raises the likelihood of recessive forms. Counselors can discuss this sensitively and plan testing for the family.
Lifestyle risk factors
Retinitis pigmentosa 84 is inherited; lifestyle habits do not cause it, but they can influence symptoms, daily functioning, and the pace of vision changes. Understanding how lifestyle affects Retinitis pigmentosa 84 can help you protect remaining vision and quality of life. The elements below link everyday choices to retinal stress, blood flow, and photoreceptor support.
Frequent, intense sunlight can raise phototoxic and oxidative stress on fragile photoreceptors, potentially accelerating field loss. Consistent use of UV/blue‑blocking sunglasses and brimmed hats can reduce light burden outdoors.
Tobacco and vape aerosols increase oxidative stress and impair ocular blood flow, which may hasten rod‑cone degeneration in RP84. Quitting can help preserve remaining peripheral and night vision.
Diets low in omega‑3s and carotenoids offer less membrane and antioxidant support for photoreceptors and the retinal pigment epithelium. Higher omega‑3 intake has been associated with slower functional decline in people with retinitis pigmentosa under medical care.
Heavy drinking disrupts vitamin A metabolism and elevates oxidative stress, which can worsen night blindness and light‑adaptation problems. Limiting alcohol protects retinal health and the liver if vitamin A–based therapies are considered.
Risk prevention
Retinitis pigmentosa 84 is inherited, so there’s no known way to prevent the condition itself. Prevention is about lowering risk, not eliminating it completely. Focus instead on avoiding preventable damage, catching complications early, and planning for future family decisions. Small, consistent steps can protect vision function and safety over time.
A genetic counselor can explain how retinitis pigmentosa 84 runs in families and what your personal risks look like. They can also help relatives decide whether testing makes sense.
If you plan to have children, ask about carrier testing, IVF with embryo testing, or prenatal testing. These options can lower the chance of passing on retinitis pigmentosa 84.
Yearly or specialist-recommended visits help catch cataracts, swelling in the retina, or other treatable issues early. Early treatment can protect remaining vision and daily independence.
Wear UV400 sunglasses and a brimmed hat outdoors to reduce light stress on the retina. Tinted lenses or filters may ease glare and improve comfort for people with retinitis pigmentosa 84.
Transmission
Retinitis pigmentosa 84 is not contagious; you can’t catch it or spread it through everyday contact or bodily fluids. It happens because of a change in a gene, so transmission occurs through family inheritance, not infection.
How Retinitis pigmentosa 84 is inherited varies with the gene involved—sometimes one altered copy from one parent is enough, other times a child needs altered copies from both parents, and occasionally the change appears for the first time in the child. Because the pattern differs by family, the chance of passing it on to siblings or future children depends on the specific genetic finding, and a visit with a genetics professional can clarify your family’s chances.
When to test your genes
Consider genetic testing if you have night blindness, tunnel vision, or a family history of retinitis pigmentosa, especially at diagnosis. Testing can confirm RP84, guide prognosis, tailor monitoring and low‑vision care, and determine eligibility for clinical trials or gene‑specific therapies. It also clarifies carrier and reproductive risks for relatives.
Diagnosis
For many, the first step comes when everyday activities start feeling harder, like trouble seeing in low light or bumping into things at the edges of a room. Doctors usually begin by looking for typical eye changes and patterns in the family, then confirm findings with specialized tests. Genetic testing may be offered to clarify risk or guide treatment. The goal is a clear diagnosis of Retinitis pigmentosa 84 so care can be tailored and future planning is easier.
Your eye doctor asks about night vision, side vision, and how symptoms changed over time. They also review family history to see if the pattern suggests an inherited condition.
The retina is examined for hallmark changes such as pigment clumps, narrowed vessels, and a pale optic nerve. These clinical features can strongly suggest retinitis pigmentosa subtypes like Retinitis pigmentosa 84.
Color fundus photographs document the appearance of the retina. Comparing images over time helps track progression and supports pattern recognition.
A special camera maps areas where retinal cells are stressed or lost. This can highlight rings or patches typical of retinitis pigmentosa and guide where to look more closely.
Stages of Retinitis pigmentosa 84
Retinitis pigmentosa 84 does not have defined progression stages. Early symptoms of retinitis pigmentosa 84 often include trouble seeing in dim light and a gradually narrowing side view, but the pace and pattern can vary widely from person to person, so changes are tracked over time rather than sorted into fixed steps. Diagnosis usually combines your history and a detailed eye exam with visual field testing, retinal scans (OCT), and tests of retinal function (ERG); genetic testing can help confirm the specific subtype. Early and accurate diagnosis helps you plan ahead with confidence.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with retinitis pigmentosa 84 (RP84), vision changes start subtly—trouble seeing in dim light, bumping into low objects, or needing extra time for eyes to adjust. Over years, night blindness and narrowing side vision usually progress, and later central vision can be affected. The outlook is not the same for everyone, but the pace of change varies widely by gene variant, age at onset, and overall eye health.
Doctors call this the prognosis—a medical word for likely outcomes. Most people with RP84 do not face shortened life expectancy; the condition primarily affects eyesight. Early symptoms of retinitis pigmentosa 84 can guide planning for work, driving, and home safety, and low‑vision tools often help maintain independence. Some people experience gradual vision loss that stabilizes for stretches, while others notice a steadier decline.
Genetic testing can sometimes provide more insight into prognosis. Regular eye exams, protection from bright sunlight, nutritional guidance when appropriate, and prompt treatment of complications like cataracts or swelling in the retina may slow functional loss and preserve usable vision longer. With ongoing care, many people maintain daily routines, though adaptations—high‑contrast lighting, mobility training, and magnification—become increasingly important. Talk with your doctor about what your personal outlook might look like, including how your specific gene change, family history, and current vision map to likely changes over time.
Long-term effects
Retinitis pigmentosa 84 tends to progress slowly over years, affecting how well you see in dim light and at the edges of your vision. Long-term effects vary widely, with some people losing vision more gradually than others. Early symptoms of Retinitis pigmentosa 84 often include difficulty seeing at dusk or in dark rooms.
Difficulty seeing in low light often appears first and gradually worsens. Many notice problems at dusk, in movie theaters, or during nighttime walking.
Side vision typically shrinks over time, creating a tunnel-like view. This can make it harder to notice obstacles or moving objects approaching from the sides.
Reading and face recognition may become challenging later in the course. For some with Retinitis pigmentosa 84, central detail remains clearer for years before fading.
Eyes take longer to adjust when moving from bright areas to dim spaces. This delay can make transitions between lighting conditions disorienting.
How is it to live with Retinitis pigmentosa 84?
Living with retinitis pigmentosa 84 often means adapting to a world that gradually narrows at the edges, with night vision and side vision fading first and reading or face recognition becoming harder in dim light. Many build routines around brighter lighting, high-contrast cues, magnification, and orientation and mobility training, balancing independence with practical tools like white canes or apps that describe surroundings. Friends, family, and coworkers may need gentle reminders to announce themselves, offer an elbow when crossing busy areas, or keep shared spaces free of tripping hazards, which can strengthen teamwork rather than pity. For many, support groups, low-vision specialists, and workplace or school accommodations turn daily life from constant detours into a path that’s manageable, purposeful, and connected.
Treatment and drugs
Treatment for Retinitis pigmentosa 84 focuses on protecting remaining vision, managing day-to-day challenges, and addressing related eye issues like swelling of the retina. Although living with Retinitis pigmentosa 84 can feel overwhelming, many people manage their symptoms and live fulfilling lives. Current options may include vitamin A palmitate at carefully monitored doses, omega-3–rich diets (like regular fish intake), and carbonic anhydrase inhibitors (eye drops or pills) for macular edema; a doctor will weigh benefits and risks and monitor the liver and vision closely. Low-vision rehabilitation, magnifying devices, high-contrast lighting, and orientation-and-mobility training can help maintain independence, and many find glare-reducing sunglasses useful outdoors. Research is ongoing into gene-based therapies, retinal implants, and neuroprotective treatments, so regular follow-up with a retina specialist and asking about clinical trials can keep you informed about new options.
Non-drug treatment
Living with Retinitis pigmentosa 84 can change how you get around in dim places, read signs, or feel in bright glare. Beyond prescriptions, supportive therapies can help you keep independence and protect the vision you have. People often turn to these options when early symptoms of Retinitis pigmentosa 84—like night vision difficulties or bumping into objects—begin to disrupt daily tasks. The right mix usually combines vision rehabilitation, practical tools, and safety-focused changes at home and outdoors.
Vision specialists teach ways to use your remaining sight more effectively. Structured programs, like vision rehabilitation clinics, can help set goals and teach strategies. Sessions may cover reading, cooking, and travel skills.
Training builds safe travel skills indoors and outdoors, including cane use and landmarking. It can reduce falls and anxiety in low light. Practice also prepares you for changing light conditions.
Handheld magnifiers, e-readers, and screen readers make print and screens easier to access. Voice-guided smartphone apps can help with navigation and object identification. Try several options to find the best fit.
Brighter task lights, motion-activated night-lights, and consistent lighting reduce strain. High-contrast tape or paint on steps and edges makes hazards stand out. An occupational therapist can tailor a plan.
Your genes may have an impact on how drugs work for you
Even when the diagnosis is the same, genes can change how your body handles medicines—how fast you process them, how strongly they work, and whether side effects appear. In RP84, genetic testing can guide trial choices and dosing, and helps avoid treatments unlikely to help.
Pharmacological treatments
Medications for retinitis pigmentosa 84 focus on easing eye swelling, protecting the remaining retina, and supporting vision function. While no pill can reverse vision loss, some drugs can improve central vision by reducing fluid in the macula, and select supplements may offer modest support for retinal health. This can matter early on, especially when early symptoms of retinitis pigmentosa 84—like night vision trouble—begin to affect daily tasks. Not everyone responds to the same medication in the same way.
Acetazolamide or methazolamide can reduce cystoid macular edema (retinal swelling) to sharpen central vision. They work by lowering fluid buildup inside the retina.
Dorzolamide or brinzolamide drops may help shrink macular swelling with fewer whole‑body side effects. These are often tried before or instead of pills.
Triamcinolone or a dexamethasone implant can calm stubborn retinal inflammation and fluid. Doctors weigh benefits against risks like cataracts and higher eye pressure.
Bevacizumab, ranibizumab, or aflibercept may be used if leakage from retinal vessels worsens swelling. Evidence in retinitis pigmentosa 84 is limited, so use is individualized.
Genetic influences
Retinitis pigmentosa 84 (RP84) is a genetic subtype of retinitis pigmentosa, caused by a change in a single gene that affects how the retina’s light‑sensing cells work and survive. Because it is inherited, it may show up across generations or among siblings, and the pattern seen in your family helps estimate each child’s chance of being affected. Family history is one of the strongest clues to a genetic influence. Even with the same gene change, people can develop symptoms at different ages and progress at different speeds; some relatives may carry the change without clear symptoms. Genetic testing can confirm the diagnosis of Retinitis pigmentosa 84, pinpoint the gene change, and clarify the likely inheritance pattern of Retinitis pigmentosa 84 for relatives who are thinking about family planning. Results may also open doors to research studies and, in time, could help determine eligibility for gene-based treatments as they become available.
Is Retinitis pigmentosa 84 genetic?
Genetics play a central role in Retinitis pigmentosa 84; most cases result from inherited gene changes. Variants can be autosomal dominant, recessive, or X‑linked, shaping age at onset, progression, and severity. Genetic testing clarifies the cause, guides counseling, and identifies trial eligibility.
Pharmacogenetics—how genetics influence drug effects
The specific genetic change behind Retinitis pigmentosa 84 can shape which treatments are possible, especially gene‑targeted options now in trials or development. Pharmacogenetics is the study of how genes influence drug response; in inherited retinal diseases, it mainly helps match people to gene‑replacement, gene‑editing, or RNA therapies designed for a particular gene or mutation, rather than fine‑tuning the dose of common medicines. For medicines sometimes used to manage complications—such as drops or pills for retinal swelling—there aren’t established pharmacogenetic dosing rules yet, and responses vary; not every difference in response is genetic, but other health factors and the stage of disease also play a role. A confirmed genetic diagnosis of Retinitis pigmentosa 84 can determine eligibility for clinical trials and may guide future access to targeted therapy, which can be more informative for treatment planning than early symptoms of Retinitis pigmentosa 84. Supplement use, including vitamin A, should be individualized because potential benefits and risks can depend on the underlying gene, liver health, age, and pregnancy plans; review any supplements or new medicines with your eye specialist. In short, your genetic results help your care team focus on the safest and most promising options now while positioning you for gene‑specific advances as they become available.
Interactions with other conditions
Other eye diseases can change how vision loss unfolds and is managed. If cataracts or glaucoma are present alongside Retinitis pigmentosa 84, they can narrow vision further or blur what’s left of central sight, so treating those conditions can make a meaningful difference. Early symptoms of Retinitis pigmentosa 84, such as night blindness and trouble with side vision, may be mistaken for changes from diabetes or cataracts, which is why careful exams are important when more than one issue is on the table. Talk with your doctor about how your conditions may influence each other. Some genetic forms of retinitis pigmentosa occur as part of broader syndromes that include hearing loss, kidney problems, or nerve issues; while not everyone with RP84 has these, many clinics still screen for them to be safe. Medications taken for other illnesses—such as drugs known to affect the retina—may also complicate eye findings, so bringing a full medication list to each visit helps tailor a plan that protects your remaining vision.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described night-blindness that ran in families, with relatives avoiding travel at dusk or carrying extra lamps. In some communities, younger adults noticed they struggled to see stars or read street signs at twilight long before daytime vision changed. These early accounts echo what many living with Retinitis pigmentosa 84 experience today: trouble seeing in dim light and slowly narrowing side vision.
From early theories to modern research, the story of retinitis pigmentosa (RP) moved from careful observation to gene-based understanding. In the 1800s, physicians documented the telltale “bone-spicule” pigment changes seen at the back of the eye and linked them with night blindness and shrinking visual fields. By the mid-20th century, families with multiple affected members helped doctors recognize that RP was not one disease but a group of inherited conditions with similar patterns, sometimes appearing in childhood and other times later in life.
Advances in genetics in the late 20th and early 21st centuries revealed that many different genes can cause RP. Researchers began numbering RP subtypes as they identified specific genetic causes, which is how terms like Retinitis pigmentosa 84 arose. Each numbered type reflects a distinct gene change that disturbs how the light-sensing cells of the retina work and survive. While the clinical picture—night blindness, peripheral vision loss, and eventual central vision changes—remains familiar, genetic testing made it possible to distinguish one subtype from another.
In recent decades, knowledge has built on a long tradition of observation. As labs mapped more RP genes, they uncovered why the condition can vary so widely within and between families—some people notice early symptoms of Retinitis pigmentosa 84 in childhood, while others develop noticeable changes later. This genetic clarity also reshaped counseling and opened doors for targeted research, including natural history studies that track how vision changes over years, not weeks or months.
Once considered rare, now recognized as part of a broad spectrum of inherited retinal diseases, RP—including RP84—has become a focus of coordinated international studies. Multicenter registries, modern imaging, and better field testing have refined the timelines doctors use to monitor progression. Gene discovery also encouraged clinical trials, from protective treatments to gene-specific therapies, while low-vision rehabilitation and assistive technology improved day-to-day independence.
Looking back helps explain today’s approach: careful attention to family history, precise eye exams, and, when possible, genetic testing to confirm the subtype. This path—from family stories by candlelight to named genetic types like Retinitis pigmentosa 84—shaped the care people receive now and guides ongoing efforts to preserve sight.